(UL) Unilever - Ratings and Ratios
Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US9047677045
UL: Beauty Products, Personal Care, Cleaning Supplies, Food Items, Ice Cream
Unilever PLC ADR (NYSE:UL) is a multinational consumer goods company with a diverse portfolio spanning personal care, home care, foods, and refreshment products. The company operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream. Each segment contributes to Unilevers global presence across Asia Pacific, Africa, the Americas, and Europe.
The Beauty & Wellbeing segment includes hair care products like shampoos and conditioners, skin care items such as moisturizers, and prestige beauty products, along with health supplements. Personal Care offers skin cleansing products, deodorants, and oral care items. Home Care provides fabric care products and home hygiene solutions. The Foods segment includes cooking aids and condiments, while the Ice Cream segment offers both in-home and out-of-home ice cream products.
Unilevers brand portfolio is extensive, featuring well-known names like AXE, Ben & Jerrys, Dove, Knorr, and Vaseline, among others. This diverse range of brands allows the company to cater to a wide array of consumer needs globally. Unilever PLC, founded in 1860, is headquartered in London, UK, and is recognized for its commitment to sustainability and innovation.
Based on the provided data, the 3-month forecast for Unilever PLC ADR (NYSE:UL) suggests potential moderate growth. The SMA20 of 60.01 indicates recent price strength above the SMA50 of 58.49, signaling a bullish trend. The ATR of 1.18 reflects moderate volatility. Fundamental analysis shows a high P/E of 23.16, with a forward P/E of 17.45, indicating market expectations for future growth. The RoE of 50.79% highlights strong profitability. Considering these factors, the stock is expected to trade within a range of $62 to $65 over the next quarter, supported by consistent demand for its essential products and strategic sustainability initiatives.
Additional Sources for UL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UL Stock Overview
Market Cap in USD | 154,709m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception | 1988-01-04 |
UL Stock Ratings
Growth Rating | 31.5 |
Fundamental | 57.7 |
Dividend Rating | 46.9 |
Rel. Strength | 10.9 |
Analysts | 4/5 |
Fair Price Momentum | 62.12 USD |
Fair Price DCF | 134.86 USD |
UL Dividends
Dividend Yield 12m | 3.96% |
Yield on Cost 5y | 5.48% |
Annual Growth 5y | 0.18% |
Payout Consistency | 92.4% |
UL Growth Ratios
Growth Correlation 3m | 87.1% |
Growth Correlation 12m | 33.9% |
Growth Correlation 5y | 31% |
CAGR 5y | 7.41% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | 1.16 |
Alpha | 17.97 |
Beta | 0.082 |
Volatility | 21.32% |
Current Volume | 2698.7k |
Average Volume 20d | 2356.1k |
As of May 09, 2025, the stock is trading at USD 62.58 with a total of 2,698,716 shares traded.
Over the past week, the price has changed by -0.65%, over one month by +8.08%, over three months by +8.31% and over the past year by +22.70%.
Partly, yes. Based on ValueRay Fundamental Analyses, Unilever (NYSE:UL) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.67 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UL as of May 2025 is 62.12. This means that UL is currently overvalued and has a potential downside of -0.74%.
Unilever has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy UL.
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, UL Unilever will be worth about 67.1 in May 2026. The stock is currently trading at 62.58. This means that the stock has a potential upside of +7.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 65.9 | 5.3% |
Analysts Target Price | 65.9 | 5.3% |
ValueRay Target Price | 67.1 | 7.2% |